Sr.No.,Schedule Date,Locality,Age,Gender,Modality,Type of Procedure(s) Requested,Type of Test(s) Requested,Test Result(s),Provisional Diagnosis,Principal Diagnosis,Additional Diagnosis,Pregnant Patient,NHIA Patient,Medicine Prescribed,Medicine Dispensed,Occupation,Ward/Room,Date of Admission,Date of Discharge,Outcome of Discharge,Surgical Procedure,Cost of Treatment (GHS ),Admission Type,E-tracking Number
9,30-09-2024,NEW-WEIJA,55 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,WAREHOUSE OFFICER,,30-09-2024,30-09-2024,,,30,OPD,
121,30-09-2024,ODORKOR,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.319 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema]  ==> OLD,,No,Non-Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | OD |  For 5 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",,,30-09-2024,30-09-2024,,,10,OPD,
123,30-09-2024,scc red top ,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Non-Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,30-09-2024,30-09-2024,,,0,OPD,
124,30-09-2024,ablekuman nic,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 60 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ]",,,30-09-2024,30-09-2024,,,0,OPD,
129,30-09-2024,BORTIANOR,75 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Unemployed,,30-09-2024,30-09-2024,,,0,OPD,
167,30-09-2024,ablekuma pentecost junction,56 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,30-09-2024,30-09-2024,,,60,OPD,
189,30-09-2024,"SANTA MARIA , A-LANG ",57 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.22 [Diabetes mellitus due to underlying condition with diabetic chronic kidney disease]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLICLAZIDE [ DIAMICRON | 80MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLICLAZIDE [ DIAMICRON | 80MG | Tablet ]",MECHANIC,,30-09-2024,30-09-2024,,,15,OPD,
193,30-09-2024,AGAPE UP TWON,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.42 [Diabetes mellitus due to underlying condition with diabetic polyneuropathy]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet | OD |  For 60 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet ]",Para Professional,,30-09-2024,30-09-2024,,,0,OPD,
202,30-09-2024,KASOA BARRIER,86 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet | OD |  For 30 Days  ], POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel | OD |  For 10 Days  ], SUCRALFATE+OXETACAINE SUSPENSION[ SUCRAFIL- O   | 100ML | Suspension | BDS |  For 10 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet ], POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel ], SUCRALFATE+OXETACAINE SUSPENSION[ SUCRAFIL- O   | 100ML | Suspension ]",,,30-09-2024,30-09-2024,,,10,OPD,
218,30-09-2024,kasao,48 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,30-09-2024,30-09-2024,,,10,OPD,
563,30-09-2024,KASOA,69 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,,,30-09-2024,30-09-2024,,,0,OPD,
799,30-09-2024,KASOA COLUMBA,63 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,UNCONTROLLED DM ,"E08.3291 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, right eye]  ==> OLD","H18.12 [Bullous keratopathy, left eye]  ==> NEW, H25.1 [Senile nuclear cataract]  ==> OLD",No,Non-Insured,,,TRADER,,30-09-2024,30-09-2024,,,0,OPD,
1010,29-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,29-09-2024,29-09-2024,,,0,OPD,
1040,29-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,29-09-2024,29-09-2024,,,30,OPD,
1042,29-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,29-09-2024,29-09-2024,,,10,OPD,
1059,29-09-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,29-09-2024,29-09-2024,,,50,OPD,
1184,28-09-2024,NEW-WEIJA,55 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,WAREHOUSE OFFICER,,28-09-2024,28-09-2024,,,70,OPD,
1186,28-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,28-09-2024,28-09-2024,,,10,OPD,
1187,28-09-2024,tetegu,54 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,28-09-2024,28-09-2024,,,20,OPD,
1194,28-09-2024,"WEIJA
MANDELA",49 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,28-09-2024,28-09-2024,,,10,OPD,
1219,28-09-2024,BORTIANOR,75 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Unemployed,,28-09-2024,28-09-2024,,,0,OPD,
1290,28-09-2024,"KASOA
DOMEABRA",58 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,A01.0 [Typhoid fever]  ==> NEW,No,Insured,"CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 14 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]",,GOLDSMITH,,28-09-2024,28-09-2024,,,10,OPD,
1382,27-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,27-09-2024,27-09-2024,,,20,OPD,
1383,27-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,27-09-2024,27-09-2024,,,0,OPD,
1391,27-09-2024,KWASHIEMAN,57 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,27-09-2024,27-09-2024,,,0,OPD,
1450,27-09-2024,BLOCK FACTORY OLD SOLDIER LINE,63 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | 6x/day |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,27-09-2024,27-09-2024,,,10,OPD,
1465,27-09-2024,SCC 38DELMONT STR,68 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],Unemployed,,27-09-2024,27-09-2024,,,0,OPD,
1467,27-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,27-09-2024,27-09-2024,,,0,OPD,
1575,27-09-2024,OLD BARRIER  APLAKU ,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,27-09-2024,27-09-2024,,,0,OPD,
1612,27-09-2024,anyaa,39 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,27-09-2024,27-09-2024,,,0,OPD,
1760,27-09-2024,NEW BORTIANOR,51 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,INSURANCE AGENT,,27-09-2024,27-09-2024,,,20,OPD,
1890,27-09-2024,MALLAM JUNC,69 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,"E11.40 [Type 2 diabetes mellitus with diabetic neuropathy, unspecified]  ==> OLD",I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,27-09-2024,27-09-2024,,,0,OPD,
2039,26-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,26-09-2024,26-09-2024,,,10,OPD,
2059,26-09-2024,AWOSHIE,51 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,TRADER,,26-09-2024,26-09-2024,,,60,OPD,
2117,26-09-2024,DOMEABRA,53 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 0 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 0 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 0 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ]",,,26-09-2024,26-09-2024,,,10,OPD,
2126,26-09-2024,mcathy down,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,26-09-2024,26-09-2024,,,20,OPD,
2133,26-09-2024,AYIGBE TOWN,35 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,26-09-2024,26-09-2024,,,10,OPD,
2148,26-09-2024,nwe aplaku,76 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BID |  For 5 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 60 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,26-09-2024,26-09-2024,,,20,OPD,
2161,26-09-2024,ablekuman,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,26-09-2024,26-09-2024,,,0,OPD,
2174,26-09-2024,MALLAM ABASE,52 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,G90.0 [Idiopathic peripheral autonomic neuropathy]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,26-09-2024,26-09-2024,,,10,OPD,
2181,26-09-2024,"ALIU MAHAMA ROAD
DANSOMAN ",74 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,26-09-2024,26-09-2024,,,10,OPD,
2186,26-09-2024,KASOA CP TOP HILL,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"E10.40 [Type 1 diabetes mellitus with diabetic neuropathy, unspecified]  ==> OLD",I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ]",,,,26-09-2024,26-09-2024,,,10,OPD,
2199,26-09-2024,WEIJA OLD BARRIER,63 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, I64.00 [Stroke, not specified as haemorrhage or infarction]  ==> OLD, D50.0 [Iron deficiency anaemia secondary to blood loss (chronic)]  ==> OLD",No,Insured,"ROSUVASTATIN [ ROSUVASTATIN  | 5MG | Tablet | Nocte |  For 0 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 0 Days  ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | Daily |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ], MULTIVITAMIN TABLET[ MULTIVITAMIN |  | Tablet | TDS |  For 30 Days  ]",,Teacher,,26-09-2024,26-09-2024,,,10,OPD,25316/18  MR-11B-E7-81
2212,26-09-2024,MACCARTHY HILLS,40 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ]",hairdresser,,26-09-2024,26-09-2024,,,10,OPD,
2223,26-09-2024,WEIJA ITS,55 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,26-09-2024,26-09-2024,,,60,OPD,
2256,26-09-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,26-09-2024,26-09-2024,,,30,OPD,
2297,26-09-2024,lower mccarthy,69 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,26-09-2024,26-09-2024,,,60,OPD,
2417,26-09-2024,KASOA ,73 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,Unemployed,,26-09-2024,26-09-2024,,,0,OPD,
2709,26-09-2024,OBLOGO,68 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,I16.0 [Hypertensive urgency]  ==> OLD,No,Insured,"LABETALOL INJECTION 100MG[ LABETALOL | 5MG/ML 20ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 7 Days  ]","LABETALOL INJECTION 100MG[ LABETALOL | 5MG/ML 20ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,26-09-2024,26-09-2024,,,85,OPD,
2778,26-09-2024,SANTA MARIA,66 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"R52.0 [Acute pain]  ==> NEW, N34.1 [Nonspecific urethritis]  ==> NEW",No,Non-Insured,"TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ]","TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,26-09-2024,26-09-2024,,,70,OPD,
2822,25-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,25-09-2024,25-09-2024,,,0,OPD,
2835,25-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,25-09-2024,25-09-2024,,,0,OPD,
2839,25-09-2024,"WEIJA
MANDELA",49 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,25-09-2024,25-09-2024,,,0,OPD,
2881,25-09-2024,AKWELEY NEW TOWN,52 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,25-09-2024,25-09-2024,,,10,OPD,
2883,25-09-2024,oblogo,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,25-09-2024,25-09-2024,,,10,OPD,
2919,25-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,25-09-2024,25-09-2024,,,20,OPD,
2923,25-09-2024,new gbawe,75 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,25-09-2024,25-09-2024,,,70,OPD,
2987,25-09-2024,"gbawe
bulemi",72 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 60 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 60 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 60 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ]",,,,25-09-2024,25-09-2024,,,0,OPD,
3011,25-09-2024,KASOA COLUMBA,63 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,"E08.3211 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye]  ==> NEW",,No,Non-Insured,,,TRADER,,25-09-2024,25-09-2024,,,10,OPD,
3099,25-09-2024,AKOM,58 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,25-09-2024,25-09-2024,,,0,OPD,
3101,25-09-2024,MALLAM KOKROKO,67 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,"E08.3213 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral]  ==> OLD",,No,Insured,,,TRADER,,25-09-2024,25-09-2024,,,0,OPD,
3128,25-09-2024,PIG FARM,68 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 0 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 0 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 0 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,25-09-2024,25-09-2024,,,10,OPD,
3169,25-09-2024,NEW BORTIANOR,51 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,INSURANCE AGENT,,25-09-2024,25-09-2024,,,10,OPD,
3189,25-09-2024,KWASHIEBU,88 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,25-09-2024,25-09-2024,,,10,OPD,7533/16 MR-4A-E6-90
3360,25-09-2024,SAMPA VALLEY WEIJA,68 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 1 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Pensioner,,25-09-2024,25-09-2024,,,135,OPD,
3401,25-09-2024,WEIJA KOKOBEN,57 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ],,,,25-09-2024,25-09-2024,,,20,OPD,
3460,25-09-2024,mallam,75 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,25-09-2024,25-09-2024,,,0,OPD,
3538,25-09-2024,AWOSHIE,46 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 7 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TEACHER,,25-09-2024,25-09-2024,,,70,OPD,
3679,24-09-2024,tetegu,54 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,24-09-2024,24-09-2024,,,20,OPD,
3680,24-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,24-09-2024,24-09-2024,,,10,OPD,
3681,24-09-2024,NEW-WEIJA,55 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,WAREHOUSE OFFICER,,24-09-2024,24-09-2024,,,50,OPD,
3730,24-09-2024,agape,57 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,24-09-2024,24-09-2024,,,50,OPD,
3750,24-09-2024,AGAPE ,59 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> NEW,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 14 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TRADER,,24-09-2024,24-09-2024,,,0,OPD,
3805,24-09-2024,MALLAM KOKROKO,67 Year(s),Female,EYE CLINIC ,Review Consultation Adult ,,No Outcome,NA ,"E08.3213 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral]  ==> OLD",,No,Insured,,,TRADER,,24-09-2024,24-09-2024,,,0,OPD,
3815,24-09-2024,CHINIS,46 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,,,,,24-09-2024,24-09-2024,,,50,OPD,
3816,24-09-2024,new weija azumah,65 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], CLINDAMYCIN CAPSULE 150MG[ CLINDAMYCIN | 150MG | Capsule | QID |  For 7 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLINDAMYCIN CAPSULE 150MG[ CLINDAMYCIN | 150MG | Capsule ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,24-09-2024,24-09-2024,,,0,OPD,
3818,24-09-2024,MCCARTHY HILL,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ]","TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,24-09-2024,24-09-2024,,,0,OPD,
3833,24-09-2024,ABLEKUMAN,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.319 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Once |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ]",,,,24-09-2024,24-09-2024,,,10,OPD,
3834,24-09-2024,BORTIANOR,75 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Unemployed,,24-09-2024,24-09-2024,,,0,OPD,
3838,24-09-2024,OBLOGO,50 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet | Daily |  For 60 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 60 Days  ]","LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",Para Professional,,24-09-2024,24-09-2024,,,0,OPD,
3851,24-09-2024,KASOA OLD BARRIER-KINGDOM HALL ROAD,49 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",beautician,,24-09-2024,24-09-2024,,,0,OPD,
3852,24-09-2024,WEIJA ITS,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"E08.3211 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye]  ==> OLD",I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ]",,,24-09-2024,24-09-2024,,,40,OPD,
3857,24-09-2024,"WEIJA
BARRIER",63 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ]",,Pensioner,,24-09-2024,24-09-2024,,,10,OPD,
3877,24-09-2024,McCarthy,80 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ]",,,,24-09-2024,24-09-2024,,,10,OPD,
4046,24-09-2024,weija choice,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]",,,,24-09-2024,24-09-2024,,,0,OPD,
4072,24-09-2024,GBAWE,69 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet | Daily |  For 90 Days  ], PIRACETAM TABLET 800MG[ PIRACETAM | 800MG | Tablet | OD |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet ], PIRACETAM TABLET 800MG[ PIRACETAM | 800MG | Tablet ]",,,24-09-2024,24-09-2024,,,0,OPD,
4079,24-09-2024,scc behind new vision hotel,58 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]",,,,24-09-2024,24-09-2024,,,20,OPD,
4087,24-09-2024,tetegu,63 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,24-09-2024,24-09-2024,,,10,OPD,
4228,24-09-2024,Kasoa,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,24-09-2024,24-09-2024,,,60,OPD,
4242,24-09-2024,gbawe top base,77 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ]",,,,24-09-2024,24-09-2024,,,0,OPD,
4247,24-09-2024,KASOA COLUMBA,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ]",,TRADER,,24-09-2024,24-09-2024,,,10,OPD,
4278,24-09-2024,LAPAZ,55 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,,,24-09-2024,24-09-2024,,,50,OPD,
4323,24-09-2024,GBAWE,74 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,,,24-09-2024,24-09-2024,,,50,OPD,
4389,24-09-2024,KASOA AKWELEY,61 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]","AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,24-09-2024,24-09-2024,,,10,OPD,
4822,23-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,23-09-2024,23-09-2024,,,40,OPD,
4835,23-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,23-09-2024,23-09-2024,,,0,OPD,
4859,23-09-2024,KASOA OTA CITY,66 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E10.40 [Type 1 diabetes mellitus with diabetic neuropathy, unspecified]  ==> NEW","N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 8 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 8 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 8 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",TRADER,,23-09-2024,23-09-2024,,,10,OPD,
4898,23-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,23-09-2024,23-09-2024,,,0,OPD,
4906,23-09-2024,GBAWE  JULICART,53 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.69 [Diabetes mellitus due to underlying condition with other specified complication]  ==> OLD,,No,Insured,,,Teacher,,23-09-2024,23-09-2024,,,160,OPD,
4940,23-09-2024,new bortianor,57 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,23-09-2024,23-09-2024,,,0,OPD,
5012,23-09-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,23-09-2024,23-09-2024,,,40,OPD,
5063,23-09-2024,OLD BARRIER  APLAKU ,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,23-09-2024,23-09-2024,,,0,OPD,
5191,22-09-2024,tetegu,54 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,22-09-2024,22-09-2024,,,0,OPD,
5193,22-09-2024,NEW-WEIJA,55 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,WAREHOUSE OFFICER,,22-09-2024,22-09-2024,,,50,OPD,
5196,22-09-2024,"WEIJA
MANDELA",49 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,22-09-2024,22-09-2024,,,0,OPD,
5204,22-09-2024,KWASHIEMAN,57 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,22-09-2024,22-09-2024,,,10,OPD,
5209,22-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,22-09-2024,22-09-2024,,,0,OPD,
5222,22-09-2024,BORTIANOR,75 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Unemployed,,22-09-2024,22-09-2024,,,0,OPD,
5238,22-09-2024,ODORKOR ,52 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Non-Insured,,,TRADER,,22-09-2024,22-09-2024,,,60,OPD,
5257,22-09-2024,NEW BORTIANOR,51 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,INSURANCE AGENT,,22-09-2024,22-09-2024,,,0,OPD,
5382,21-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,21-09-2024,21-09-2024,,,60,OPD,
5387,21-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,21-09-2024,21-09-2024,,,10,OPD,
5436,21-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,21-09-2024,21-09-2024,,,0,OPD,
5463,21-09-2024,OLD BARRIER  APLAKU ,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,21-09-2024,21-09-2024,,,10,OPD,
5591,20-09-2024,tetegu,54 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,20-09-2024,20-09-2024,,,0,OPD,
5592,20-09-2024,NEW-WEIJA,55 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,WAREHOUSE OFFICER,,20-09-2024,20-09-2024,,,20,OPD,
5622,20-09-2024,GBAWE  JULICART,53 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.69 [Diabetes mellitus due to underlying condition with other specified complication]  ==> OLD,,No,Insured,,,Teacher,,20-09-2024,20-09-2024,,,70,OPD,
5628,20-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,20-09-2024,20-09-2024,,,0,OPD,
5676,20-09-2024,gbawe,64 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.36 [Diabetes mellitus due to underlying condition with diabetic cataract]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,20-09-2024,20-09-2024,,,10,OPD,
5678,20-09-2024,"Awoshie
apostle safo",69 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]","TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,20-09-2024,20-09-2024,,,10,OPD,
5684,20-09-2024,ksaoa,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | TID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,20-09-2024,20-09-2024,,,0,OPD,
5780,20-09-2024,BORTIANOR,75 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Unemployed,,20-09-2024,20-09-2024,,,10,OPD,
5821,20-09-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,20-09-2024,20-09-2024,,,30,OPD,
5880,20-09-2024,NEW BORTIANOR,51 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,INSURANCE AGENT,,20-09-2024,20-09-2024,,,0,OPD,
6066,20-09-2024,MCCARTHY JUNCTION,59 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,20-09-2024,20-09-2024,,,0,OPD,30308/17  MR-1B-A6-8
6282,19-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,19-09-2024,19-09-2024,,,20,OPD,
6290,19-09-2024,"WEIJA
MANDELA",49 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,19-09-2024,19-09-2024,,,10,OPD,
6305,19-09-2024,KWASHIEMAN,57 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,19-09-2024,19-09-2024,,,0,OPD,
6306,19-09-2024,KASOA,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.42 [Diabetes mellitus due to underlying condition with diabetic polyneuropathy]  ==> OLD,,No,Insured,,,,,19-09-2024,19-09-2024,,,0,OPD,
6330,19-09-2024,malam,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,19-09-2024,19-09-2024,,,0,OPD,
6333,19-09-2024,mccarthy,44 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLICLAZIDE [ DIAMICRON | 60MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 60 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 60 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 0 Days  ]","GLICLAZIDE [ DIAMICRON | 60MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,19-09-2024,19-09-2024,,,10,OPD,
6391,19-09-2024,GBAWE,74 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,,No,Insured,"VITAMIN B1+B2+B6+B12+GLUTAMIC ACID[ NEURO-MIN PLUS |  | Tablet | OD |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 1 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","VITAMIN B1+B2+B6+B12+GLUTAMIC ACID[ NEURO-MIN PLUS |  | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,19-09-2024,19-09-2024,,,10,OPD,
6408,19-09-2024,AWOSHIE,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ANTIOXIDANTS/LYCOPENE/AMINO ACIDS/DHA/ALPHA LIPOIC[ SIDME PRO |  |  | BDS |  For 30 Days  ]","GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ANTIOXIDANTS/LYCOPENE/AMINO ACIDS/DHA/ALPHA LIPOIC[ SIDME PRO |  |  ]",,,19-09-2024,19-09-2024,,,0,OPD,
6422,19-09-2024,apleku,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,19-09-2024,19-09-2024,,,10,OPD,
6445,19-09-2024,SCC ADB BANK,49 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,,,Unemployed,,19-09-2024,19-09-2024,,,50,OPD,
6480,19-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,19-09-2024,19-09-2024,,,30,OPD,
6486,19-09-2024,OLD BARRIER  APLAKU ,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,19-09-2024,19-09-2024,,,0,OPD,
6495,19-09-2024,amanfo,33 Year(s),Male,SPECIALIST CLINIC ,CONSULTATION (ADULT),,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ],,,,19-09-2024,19-09-2024,,,170,OPD,
6504,19-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,19-09-2024,19-09-2024,,,0,OPD,
6527,19-09-2024,weija katapilar,39 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ]","PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,19-09-2024,19-09-2024,,,60,OPD,
6533,19-09-2024,"DARKUMAN
LOVERS INN",56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | Daily |  For 60 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ]","AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",TRADER,,19-09-2024,19-09-2024,,,10,OPD,
6594,19-09-2024,MENDS KRROM,68 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,19-09-2024,19-09-2024,,,50,OPD,
6604,19-09-2024,TETEGU,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], INDAPAMIDE SR [ Natrilix | 1.5MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel | PRN |  For 8 Days  ]",,,,19-09-2024,19-09-2024,,,60,OPD,44011/19
6642,19-09-2024,LAPAZ,89 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.621 [Type 1 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,Unemployed,,19-09-2024,19-09-2024,,,80,OPD,
6690,19-09-2024,"MALLAM , BEHIND LAFA POLICE STATION ",66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 60 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel | PRN |  For 5 Days  ]","PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel ]",,,19-09-2024,19-09-2024,,,10,OPD,
6784,19-09-2024,"GBAWE
BULEMIN",48 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,19-09-2024,19-09-2024,,,50,OPD,
6796,19-09-2024,"GBAWE , TOP BASE",46 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Stat |  For 30 Days  ]",,CLEGY,,19-09-2024,19-09-2024,,,10,OPD,
6813,19-09-2024,malam,65 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,19-09-2024,19-09-2024,,,50,OPD,
6817,19-09-2024,ODORKOR,61 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.319 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema]  ==> RECURRING,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,19-09-2024,19-09-2024,,,0,OPD,
6912,19-09-2024,"KASOA
OBUOM",68 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M47.8 [Other spondylosis]  ==> NEW, D25.9 [Leiomyoma of uterus, unspecified]  ==> OLD",No,Non-Insured,"PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], ENOXAPARIN SODIUM (CLEXANE) INJECTION 40MG[ CLEXANE | 40MG/0.4ML | Injection | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ]",,none,,19-09-2024,19-09-2024,,,350,OPD,
7042,18-09-2024,NEW-WEIJA,55 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,WAREHOUSE OFFICER,,18-09-2024,18-09-2024,,,40,OPD,
7048,18-09-2024,tetegu,54 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,18-09-2024,18-09-2024,,,20,OPD,
7074,18-09-2024,NEW GBAWE,68 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E10.40 [Type 1 diabetes mellitus with diabetic neuropathy, unspecified]  ==> NEW",,No,Insured,"VITAMIN B1+B2+B6+B12+GLUTAMIC ACID[ NEURO-MIN PLUS |  | Tablet | OD |  For 30 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 7 Days  ]",,Pensioner,,18-09-2024,18-09-2024,,,0,OPD,
7086,18-09-2024,GBAWE  JULICART,53 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.69 [Diabetes mellitus due to underlying condition with other specified complication]  ==> OLD,,No,Insured,,,Teacher,,18-09-2024,18-09-2024,,,130,OPD,
7164,18-09-2024,keneshie ,78 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 60 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,18-09-2024,18-09-2024,,,10,OPD,
7301,18-09-2024,KALABULE,27 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,TRADER,,18-09-2024,18-09-2024,,,60,OPD,
7338,18-09-2024,"ABLEKUMA
AGAPE DOWN",52 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | TDS |  For 2 Days  ],,Unemployed,,18-09-2024,18-09-2024,,,30,OPD,
7393,18-09-2024,BORTIANOR,75 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Unemployed,,18-09-2024,18-09-2024,,,10,OPD,
7406,18-09-2024,NEW BORTIANOR,51 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,INSURANCE AGENT,,18-09-2024,18-09-2024,,,10,OPD,
7521,18-09-2024,ABEKA,59 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ]",driver,,18-09-2024,18-09-2024,,,10,OPD,
7547,18-09-2024,"GBAWE , ZERO ",67 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Non-Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | OD |  For 90 Days  ],,PENSIONEER,,18-09-2024,18-09-2024,,,10,OPD,
7565,18-09-2024,"WEIJA BEHIND
SECONDARY SCH",49 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,CHEF,,18-09-2024,18-09-2024,,,20,OPD,
7891,17-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,17-09-2024,17-09-2024,,,0,OPD,
7918,17-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,17-09-2024,17-09-2024,,,20,OPD,
7968,17-09-2024,FETTEH KAKRABA,52 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]",,TRADER,,17-09-2024,17-09-2024,,,10,OPD,
7977,17-09-2024,KASOA-OLD BORTIANOR,60 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,"F31.4 [Bipolar affective disorder, current episode severe depression without psychotic symptoms]  ==> OLD, G24.01 [Drug induced subacute dyskinesia]  ==> OLD, G99.0* [Autonomic neuropathy in endocrine and metabolic diseases]  ==> OLD, I10.00 [Essential (primary) hypertension]  ==> OLD, K73.9 [Chronic hepatitis, unspecified]  ==> NEW",No,Insured,"PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | Daily |  For 30 Days  ], LIVOLIN FORTE CAPSUES[ LIV 52 |  | Capsule | Daily |  For 30 Days  ]",,,,17-09-2024,17-09-2024,,,0,OPD,
7993,17-09-2024,gbawe,84 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,17-09-2024,17-09-2024,,,10,OPD,
7998,17-09-2024,new bortianor,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 60 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",,,17-09-2024,17-09-2024,,,5,OPD,
8004,17-09-2024,,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-09-2024,17-09-2024,,,10,OPD,
8005,17-09-2024,awoshie,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet | BDS |  For 30 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-09-2024,17-09-2024,,,10,OPD,
8008,17-09-2024,TESANO,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,17-09-2024,17-09-2024,,,10,OPD,
8009,17-09-2024,ABLEKUMAN,61 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 60 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,17-09-2024,17-09-2024,,,10,OPD,
8017,17-09-2024,ABLEKUMA,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,17-09-2024,17-09-2024,,,10,OPD,
8024,17-09-2024,ablekuman,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet | BDS |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet ]",,,17-09-2024,17-09-2024,,,0,OPD,
8044,17-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,17-09-2024,17-09-2024,,,30,OPD,
8118,17-09-2024,"GBAWE
AYI QUARTEY LANE",65 Year(s),Male,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,,,Pensioner,,17-09-2024,17-09-2024,,,10,OPD,
8126,17-09-2024,"WEIJA BEHIND
SECONDARY SCH",49 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,CHEF,,17-09-2024,17-09-2024,,,20,OPD,
8172,17-09-2024,AGAPE ,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,17-09-2024,17-09-2024,,,10,OPD,
8174,17-09-2024,OLD BARRIER  APLAKU ,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,17-09-2024,17-09-2024,,,0,OPD,
8175,17-09-2024,awoshie,46 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 90 Days  ]","PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-09-2024,17-09-2024,,,10,OPD,
8202,17-09-2024,SOWUTUOM,66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",none,,17-09-2024,17-09-2024,,,10,OPD,
8243,17-09-2024,SAKAMAN,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"ANTIOXIDANTS/LYCOPENE/AMINO ACIDS/DHA/ALPHA LIPOIC[ SIDME PRO |  |  | BDS |  For 30 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 60 Days  ]","ANTIOXIDANTS/LYCOPENE/AMINO ACIDS/DHA/ALPHA LIPOIC[ SIDME PRO |  |  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Unemployed,,17-09-2024,17-09-2024,,,15,OPD,
8277,17-09-2024,GBAWE ZERO,74 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-09-2024,17-09-2024,,,10,OPD,
8328,17-09-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,17-09-2024,17-09-2024,,,40,OPD,
8334,17-09-2024,WEST HILL,63 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,17-09-2024,17-09-2024,,,0,OPD,
8378,17-09-2024,SCC ADB BANK,49 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,K29.1 [Other acute gastritis]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 14 Days  ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension | PRN |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension ]",Unemployed,,17-09-2024,17-09-2024,,,70,OPD,
8455,17-09-2024,BODOMASI,46 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ]",,,17-09-2024,17-09-2024,,,0,OPD,
8543,17-09-2024,KASOA-BROADCASTING ,51 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.69 [Type 2 diabetes mellitus with other specified complication]  ==> OLD,,No,Insured,,,Unemployed,,17-09-2024,17-09-2024,,,90,OPD,
8678,16-09-2024,AMANFRO -NEAR THE CHURCH OF PENTECOST,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,16-09-2024,16-09-2024,,,50,OPD,
8704,16-09-2024,NEW-WEIJA,55 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,WAREHOUSE OFFICER,,16-09-2024,16-09-2024,,,40,OPD,
8705,16-09-2024,tetegu,54 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,16-09-2024,16-09-2024,,,0,OPD,
8718,16-09-2024,KWASHIEMAN,57 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,16-09-2024,16-09-2024,,,10,OPD,
8720,16-09-2024,CHINIS,46 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,,No,Insured,,,,,16-09-2024,16-09-2024,,,10,OPD,
8739,16-09-2024,"WEIJA BEHIND
SECONDARY SCH",49 Year(s),Male,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,,No,Insured,"CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 7 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Daily |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Nocte |  For 30 Days  ]","CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",CHEF,,16-09-2024,16-09-2024,,,40,OPD,
8747,16-09-2024,"WEIJA
MANDELA",49 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,16-09-2024,16-09-2024,,,0,OPD,
8813,16-09-2024,UPPER WEIJA,50 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Non-Insured,,,driver,,16-09-2024,16-09-2024,,,50,OPD,
8818,16-09-2024,new bortianor,71 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-09-2024,16-09-2024,,,0,OPD,
8824,16-09-2024,kasoa,67 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BDS |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",,,16-09-2024,16-09-2024,,,10,OPD,
8834,16-09-2024,awoshie,86 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-09-2024,16-09-2024,,,0,OPD,
8835,16-09-2024,ABLEKUMA,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"E11.40 [Type 2 diabetes mellitus with diabetic neuropathy, unspecified]  ==> OLD",I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 60 Days  ]","NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",pension,,16-09-2024,16-09-2024,,,0,OPD,
8840,16-09-2024,kasao,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | OD |  For 7 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,16-09-2024,16-09-2024,,,10,OPD,
8851,16-09-2024,ODORKOR,40 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]",,,,16-09-2024,16-09-2024,,,10,OPD,
8852,16-09-2024,kasoa,78 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,16-09-2024,16-09-2024,,,0,OPD,
8857,16-09-2024,ablekuma pentecost junction,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | OD |  For 7 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]",,,,16-09-2024,16-09-2024,,,10,OPD,
8858,16-09-2024,ANYAA,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 60 Days  ],,,,16-09-2024,16-09-2024,,,10,OPD,
8859,16-09-2024,MALLAM MARKET,71 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> OLD",I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet | BDS |  For 60 Days  ], CARVEDILOL 6.25MG[  |  |  | BID |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet ], CARVEDILOL 6.25MG[  |  |  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-09-2024,16-09-2024,,,10,OPD,
8864,16-09-2024,ABLEKUMAN,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ],,,,16-09-2024,16-09-2024,,,10,OPD,
8867,16-09-2024,dankuman,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ]",,,16-09-2024,16-09-2024,,,10,OPD,
8875,16-09-2024,GBAWE  JULICART,53 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.69 [Diabetes mellitus due to underlying condition with other specified complication]  ==> OLD,,No,Insured,,,Teacher,,16-09-2024,16-09-2024,,,90,OPD,
9011,16-09-2024,BORTIANOR,75 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Unemployed,,16-09-2024,16-09-2024,,,0,OPD,
9044,16-09-2024,"ODORKOR , GLORY LAND",65 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], GLICLAZIDE [ DIAMICRON | 60MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLICLAZIDE [ DIAMICRON | 60MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-09-2024,16-09-2024,,,0,OPD,
9116,16-09-2024,ODORKOR STATION ,40 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,,,TRADER,,16-09-2024,16-09-2024,,,50,OPD,
9159,16-09-2024,AWOSHIE - MANGOASE,32 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],ENVIRONMENTAL OFFICER,,16-09-2024,16-09-2024,,,10,OPD,
9163,16-09-2024,AWOSHIE MANGOASE ,77 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,16-09-2024,16-09-2024,,,10,OPD,
9209,16-09-2024,tetegu,48 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,16-09-2024,16-09-2024,,,50,OPD,
9230,16-09-2024,new gbawe,75 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,16-09-2024,16-09-2024,,,0,OPD,
9233,16-09-2024,gbawe,66 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,16-09-2024,16-09-2024,,,0,OPD,
9236,16-09-2024,GBAWE TOP BASE,46 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet | OD |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,16-09-2024,16-09-2024,,,10,OPD,
9276,16-09-2024,KASOA ,73 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,Unemployed,,16-09-2024,16-09-2024,,,10,OPD,
9403,16-09-2024,"NEW BORTIANOR , ",53 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,TRADER,,16-09-2024,16-09-2024,,,80,OPD,
9410,16-09-2024,KASOA COLUMBA,63 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> OLD,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ]",,TRADER,,16-09-2024,16-09-2024,,,125,OPD,
9448,16-09-2024,WEIJA,46 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,,,16-09-2024,16-09-2024,,,50,OPD,
9495,16-09-2024,"ABLEKUMA
MAAME NKRAN",39 Year(s),Female,DIETERAPY,General Consultation Child,,No Outcome,NA ,"O24.410 [Gestational diabetes mellitus in pregnancy, diet controlled]  ==> OLD",,No,Insured,,,,,16-09-2024,16-09-2024,,,50,OPD,
9498,16-09-2024,"ANYAA 
DEEPER LIFE",58 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | BDS |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-09-2024,16-09-2024,,,0,OPD,
9625,15-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,15-09-2024,15-09-2024,,,20,OPD,
9660,15-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,15-09-2024,15-09-2024,,,0,OPD,
9665,15-09-2024,KASOA,62 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.42 [Diabetes mellitus due to underlying condition with diabetic polyneuropathy]  ==> NEW,,No,Insured,RENERVE PLUS-BT[  |  |  | OD |  For 30 Days  ],,,,15-09-2024,15-09-2024,,,10,OPD,
9683,15-09-2024,NEW BORTIANOR,51 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,INSURANCE AGENT,,15-09-2024,15-09-2024,,,0,OPD,
9686,15-09-2024,"ABLEKUMA,AGAPE",44 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,O00.0 [Abdominal pregnancy]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], VITAFOL TABLET[ VITAFOL |  | Tablet | OD |  For 30 Days  ]",,INSURANCE AGENT,,15-09-2024,15-09-2024,,,0,OPD,
9720,15-09-2024,TETEGO,68 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 1 Days  ], AMOXICILIN+CLAVULANIC ACID INJECTION 1.2G[ AMOKSICLAV | 1.2G | Injection | TDS |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], AMOXICILIN+CLAVULANIC ACID INJECTION 1.2G[ AMOKSICLAV | 1.2G | Injection ]",driver,,15-09-2024,15-09-2024,,,295,OPD,
9820,14-09-2024,NEW-WEIJA,55 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,WAREHOUSE OFFICER,,14-09-2024,14-09-2024,,,40,OPD,
9883,14-09-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,14-09-2024,14-09-2024,,,30,OPD,
9903,14-09-2024,BORTIANOR,75 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Unemployed,,14-09-2024,14-09-2024,,,0,OPD,
9921,14-09-2024,ABLEKUMA-VICTORY AC.,57 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Daily |  For 30 Days  ]",,BUILDING CONTRUCTOR,,14-09-2024,14-09-2024,,,0,OPD,
10060,13-09-2024,KASOA-NYANYANO,60 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> NEW,"N34.1 [Nonspecific urethritis]  ==> NEW, I10.00 [Essential (primary) hypertension]  ==> NEW, G58.9 [Mononeuropathy, unspecified]  ==> NEW, D50.8 [Other iron deficiency anaemias]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 7 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 7 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | Daily |  For 30 Days  ], CEFUROXIME TABLET 250MG[ CEFUROXIME | 250MG | Tablet | BDS |  For 7 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ], CEFUROXIME TABLET 250MG[ CEFUROXIME | 250MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",Unemployed,,13-09-2024,13-09-2024,,,10,OPD,
10062,13-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,13-09-2024,13-09-2024,,,20,OPD,
10094,13-09-2024,"KWASHIEMAN , HAPPY KIDS ",41 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,13-09-2024,13-09-2024,,,0,OPD,
10123,13-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,13-09-2024,13-09-2024,,,20,OPD,
10154,13-09-2024,BORTIANOR,68 Year(s),Female,EYE CLINIC ,Review Consultation Adult ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,E11.36 [Type 2 diabetes mellitus with diabetic cataract]  ==> OLD,No,Non-Insured,,,Unemployed,,13-09-2024,13-09-2024,,,135,OPD,
10161,13-09-2024,agape,79 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"TAB RENEURON  20MG[ RENEURON | 20MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","TAB RENEURON  20MG[ RENEURON | 20MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,13-09-2024,13-09-2024,,,0,OPD,
10171,13-09-2024,NEW  BORTIANOR,48 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,13-09-2024,13-09-2024,,,10,OPD,
10246,13-09-2024,WEST HILL,63 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,13-09-2024,13-09-2024,,,30,OPD,
10267,13-09-2024,"M24, MFRANO SUHUM",71 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,13-09-2024,13-09-2024,,,65,OPD,
10320,13-09-2024,OLD BARRIER  APLAKU ,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,13-09-2024,13-09-2024,,,70,OPD,
10450,13-09-2024,KASOA NEW MARKET ,52 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E08.3213 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral]  ==> NEW","I10.00 [Essential (primary) hypertension]  ==> NEW, A02.0 [Salmonella enteritis]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 7 Days  ], PARACETAMOL SUPPOSITORY 500MG[ PARACETAMOL | 500MG | Suppository | TID |  For 5 Days  ]",,TRADER,,13-09-2024,13-09-2024,,,70,OPD,
10531,13-09-2024,KASOA-ADADE,83 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ]",,,,13-09-2024,13-09-2024,,,295,OPD,
10594,13-09-2024,KOKRROBITE,36 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"O24.410 [Gestational diabetes mellitus in pregnancy, diet controlled]  ==> NEW",,No,Insured,,,TRADER,,13-09-2024,13-09-2024,,,50,OPD,
10628,13-09-2024,GBAWE  JULICART,53 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.69 [Diabetes mellitus due to underlying condition with other specified complication]  ==> OLD,,No,Insured,,,Teacher,,13-09-2024,13-09-2024,,,60,OPD,
10726,13-09-2024,"SANTA MARIA , A-LANG ",57 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E10.65 [Type 1 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 1 Days  ],,MECHANIC,,13-09-2024,13-09-2024,,,65,OPD,
10747,12-09-2024,WEIJA APLAKU,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,12-09-2024,12-09-2024,,,10,OPD,
10761,12-09-2024,NEW-WEIJA,55 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,WAREHOUSE OFFICER,,12-09-2024,12-09-2024,,,30,OPD,
10763,12-09-2024,tetegu,54 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,12-09-2024,12-09-2024,,,0,OPD,
10788,12-09-2024,GBAWE,74 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,"N39.0 [Urinary tract infection, site not specified]  ==> OLD",No,Insured,"GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 7 Days  ]","GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",,,12-09-2024,12-09-2024,,,60,OPD,
10810,12-09-2024,BORTIANOR,68 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,N21.8 [Other lower urinary tract calculus]  ==> NEW,No,Non-Insured,"INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Unemployed,,12-09-2024,12-09-2024,,,110,OPD,
10848,12-09-2024,camara,36 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ]",,,,12-09-2024,12-09-2024,,,0,OPD,
10853,12-09-2024,TUBA AGROW FARM,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 0 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",TRADER,,12-09-2024,12-09-2024,,,10,OPD,
10864,12-09-2024,TETEGU,67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]","METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,12-09-2024,12-09-2024,,,10,OPD,9A-D1-58
10873,12-09-2024,kasoa,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,12-09-2024,12-09-2024,,,0,OPD,
10874,12-09-2024,bulemi top,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,12-09-2024,12-09-2024,,,0,OPD,
10880,12-09-2024,ACCRA-KANTAMANTU,43 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.622 [Type 1 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,TRADER,,12-09-2024,12-09-2024,,,30,OPD,
10954,12-09-2024,mallam,59 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,12-09-2024,12-09-2024,,,0,OPD,
10956,12-09-2024,OBLOGO TOP BASE,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,12-09-2024,12-09-2024,,,10,OPD,
10968,12-09-2024,new weija,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,12-09-2024,12-09-2024,,,10,OPD,
11033,12-09-2024,NEW BORTIANOR,51 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,INSURANCE AGENT,,12-09-2024,12-09-2024,,,0,OPD,
11184,12-09-2024,kasoa,47 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,,,,,12-09-2024,12-09-2024,,,60,OPD,
11232,12-09-2024,ABLEKUMA NIC ,58 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,B50.8 [Other severe and complicated Plasmodium falciparum malaria]  ==> NEW,No,Non-Insured,"PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], SODIUM CHLORIDE NASAL DROP[ SALINE | 0.9% 10ML | Drops | Stat |  For 1 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | BDS |  For 5 Days  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet | BDS |  For 3 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], SODIUM CHLORIDE NASAL DROP[ SALINE | 0.9% 10ML | Drops ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",Unemployed,,12-09-2024,12-09-2024,,,70,OPD,
11266,12-09-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,12-09-2024,12-09-2024,,,30,OPD,
11278,12-09-2024,kasoa,54 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 60 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]",,,,12-09-2024,12-09-2024,,,10,OPD,
11320,12-09-2024,BORTIANOR,75 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Unemployed,,12-09-2024,12-09-2024,,,0,OPD,
11326,12-09-2024,ODORKOR,43 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,12-09-2024,12-09-2024,,,30,OPD,
11460,12-09-2024,"NEW GBAWE , AFTER CHURCH",49 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 7 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 14 Days  ]",,hairdresser,,12-09-2024,12-09-2024,,,0,OPD,
11508,12-09-2024,WEIJA APLAKU,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,12-09-2024,12-09-2024,,,70,OPD,
11624,12-09-2024,AWOSHIE,29 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,Yes,Insured,"INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]",,,,12-09-2024,12-09-2024,,,65,OPD,
11647,11-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,11-09-2024,11-09-2024,,,20,OPD,
11687,11-09-2024,ACCRA WEJA,64 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,11-09-2024,11-09-2024,,,50,OPD,9577/17 MR-7A-F1-23
11755,11-09-2024,MALLAM KOKROKO,67 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,E08.311 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema]  ==> NEW,,No,Insured,,,TRADER,,11-09-2024,11-09-2024,,,0,OPD,
11758,11-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,11-09-2024,11-09-2024,,,40,OPD,
11777,11-09-2024,MALLAM ABASE,52 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,,,,,11-09-2024,11-09-2024,,,60,OPD,
11880,11-09-2024,MELENUM CITY SETER 4,72 Year(s),Male,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"H25.813 [Combined forms of age-related cataract, bilateral]  ==> NEW, H40.0 [Glaucoma suspect]  ==> NEW",No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],Self Employed,,11-09-2024,11-09-2024,,,0,OPD,
11982,11-09-2024,GBAWE  JULICART,53 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.69 [Diabetes mellitus due to underlying condition with other specified complication]  ==> OLD,,No,Insured,,,Teacher,,11-09-2024,11-09-2024,,,80,OPD,
12029,11-09-2024,OLD BARRIER  APLAKU ,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,11-09-2024,11-09-2024,,,0,OPD,
12093,11-09-2024,BORTIANOR,75 Year(s),Male,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> NEW,,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 14 Days  ], AMITRIPTYLINE TABLET 50MG[ AMITRIPTYLINE | 50MG | Tablet | Nocte |  For 14 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ], DICLOFENAC INJECTION 75MG[ DICLOFENAC | 75MG/3ML | Injection | Stat |  For 1 Days  ]",,Unemployed,,11-09-2024,11-09-2024,,,0,OPD,
12246,11-09-2024,KOKROBITE,55 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,,,,,11-09-2024,11-09-2024,,,50,OPD,
12259,11-09-2024,"AWOSHIE
ONYINASE",55 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> RECURRING,"I10.00 [Essential (primary) hypertension]  ==> RECURRING, E78.4 [Other hyperlipidaemia]  ==> RECURRING",No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ]",,Unemployed,,11-09-2024,11-09-2024,,,70,OPD,
12285,11-09-2024,KASOA-CP,64 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,"DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet | OD |  For 3 Days  ], MELATONIN[ RESTWELL | 6MG | Tablet | OD |  For 14 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ]",,Unemployed,,11-09-2024,11-09-2024,,,150,OPD,
12400,11-09-2024,OTAMESS,54 Year(s),FEMALE,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"A41.9 [Sepsis, unspecified]  ==> NEW",No,Insured,"CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,11-09-2024,11-09-2024,,,10,OPD,
12557,10-09-2024,KASOA DOMEABRA,70 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",Pensioner,,10-09-2024,10-09-2024,,,10,OPD,
12558,10-09-2024,south mc carthy,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.41 [Type 2 diabetes mellitus with diabetic mononeuropathy]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ]","PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,10-09-2024,10-09-2024,,,10,OPD,
12563,10-09-2024,kasoa kalabule junction,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,10-09-2024,10-09-2024,,,0,OPD,
12564,10-09-2024,TOP BASE,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Retired,,10-09-2024,10-09-2024,,,10,OPD,
12565,10-09-2024,"UPPER WEIJA , STSTION ",50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,10-09-2024,10-09-2024,,,10,OPD,
12616,10-09-2024,santa maria,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,10-09-2024,10-09-2024,,,0,OPD,
12618,10-09-2024,odorkor,63 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",DRIVER,,10-09-2024,10-09-2024,,,10,OPD,
12737,10-09-2024,"AMANFRO
GALILEA",57 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, L02.429 [Furuncle of limb, unspecified]  ==> RECURRING",No,Non-Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | OD |  For 30 Days  ], FLUCLOXACILLIN CAPSULE 250MG[ FLUCLOXACILLIN | 250MG | Capsule | QID |  For 7 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TID |  For 5 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | OD |  For 14 Days  ]","AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], FLUCLOXACILLIN CAPSULE 250MG[ FLUCLOXACILLIN | 250MG | Capsule ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ]",,,10-09-2024,10-09-2024,,,10,OPD,
12839,10-09-2024,POKUASE,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,10-09-2024,10-09-2024,,,10,OPD,
12845,10-09-2024,ABLEKUMA,47 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,10-09-2024,10-09-2024,,,15,OPD,
12864,10-09-2024,WEST HILL,63 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,10-09-2024,10-09-2024,,,0,OPD,
12903,10-09-2024,A LAND,49 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | TID |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],driver,,10-09-2024,10-09-2024,,,80,OPD,
12934,10-09-2024,SCC ADB BANK,49 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> NEW,"N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Insured,"OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 7 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | BDS |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | TID |  For 10 Days  ]","OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Unemployed,,10-09-2024,10-09-2024,,,70,OPD,
13017,10-09-2024,ODORKOR,43 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,10-09-2024,10-09-2024,,,10,OPD,
13029,10-09-2024,KASOA ,73 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,Unemployed,,10-09-2024,10-09-2024,,,0,OPD,
13031,10-09-2024,"WEIJA, DJAMAN",60 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,10-09-2024,10-09-2024,,,0,OPD,
13268,10-09-2024,ODORKOR ,52 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Non-Insured,"CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment | BDS |  For 7 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 1 Days  ]","CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,10-09-2024,10-09-2024,,,100,OPD,
13317,09-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,09-09-2024,09-09-2024,,,20,OPD,
13323,09-09-2024,"WEIJA
MANDELA",49 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,09-09-2024,09-09-2024,,,0,OPD,
13380,09-09-2024,AWOSHIE,62 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,"E10.40 [Type 1 diabetes mellitus with diabetic neuropathy, unspecified]  ==> OLD",,No,Non-Insured,,,AUTO MECHANIC,,09-09-2024,09-09-2024,,,110,OPD,
13436,09-09-2024,BORTIANOR-ATTA STREET,62 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,09-09-2024,09-09-2024,,,0,OPD,7734/16  MR-6B-C4-17
13442,09-09-2024,mallam  government school,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 1 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | Daily |  For 1 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 1 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 1 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 1 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,09-09-2024,09-09-2024,,,10,OPD,
13484,09-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,09-09-2024,09-09-2024,,,0,OPD,
13633,09-09-2024,,69 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,09-09-2024,09-09-2024,,,50,OPD,
13637,09-09-2024,kasoa,69 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,09-09-2024,09-09-2024,,,10,OPD,
13643,09-09-2024,GBAWE  JULICART,53 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.311 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema]  ==> NEW,G89.21 [Chronic pain due to trauma]  ==> NEW,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ], POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 100ML[ DREZ  | 100ML | Solution | Every other day |  For 1 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | TID |  For 14 Days  ], DICLOFENAC TABLET 100MG[ LOFNAC | 100MG | Tablet | BID |  For 10 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 100ML[ DREZ  | 100ML | Solution ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], DICLOFENAC TABLET 100MG[ LOFNAC | 100MG | Tablet ]",Teacher,,09-09-2024,09-09-2024,,,130,OPD,
13647,09-09-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,09-09-2024,09-09-2024,,,30,OPD,
13655,09-09-2024,LAPAZ-CHANTA,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,09-09-2024,09-09-2024,,,10,OPD,
13763,09-09-2024,KASOA COLUMBA,63 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> RECURRING,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]",,TRADER,,09-09-2024,09-09-2024,,,10,OPD,
13865,09-09-2024,"GBAWE
BULEMIN",48 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,,,09-09-2024,09-09-2024,,,50,OPD,
13951,09-09-2024,new bortianor red top,63 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,09-09-2024,09-09-2024,,,50,OPD,
13974,09-09-2024,NEW BORTIANOR,51 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,INSURANCE AGENT,,09-09-2024,09-09-2024,,,10,OPD,
14061,09-09-2024,KOKROBITE,45 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",,No,Insured,,,SECRETARY,,09-09-2024,09-09-2024,,,0,OPD,
14074,09-09-2024,weija new twon,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,09-09-2024,09-09-2024,,,0,OPD,
14081,09-09-2024,"NEW GBAWE
CP",59 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]",,Unemployed,,09-09-2024,09-09-2024,,,0,OPD,
14319,09-09-2024,"KASOA
GALILEA",67 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,"CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | OD |  For 1 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ]","CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",Unemployed,,09-09-2024,09-09-2024,,,65,OPD,
14351,08-09-2024,NEW-WEIJA,55 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,WAREHOUSE OFFICER,,08-09-2024,08-09-2024,,,20,OPD,
14352,08-09-2024,tetegu,54 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,08-09-2024,08-09-2024,,,0,OPD,
14356,08-09-2024,ODORKOR,43 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,08-09-2024,08-09-2024,,,10,OPD,
14378,08-09-2024,AGAPE,85 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.641 [Diabetes mellitus due to underlying condition with hypoglycemia with coma]  ==> NEW,,No,Non-Insured,"DEXTROSE INFUSION 50%[ DEXTROSE | 50% 250ML | Infusion | Stat |  For 1 Days  ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion | Stat |  For 1 Days  ]",,Unemployed,,08-09-2024,08-09-2024,,,115,OPD,
14411,08-09-2024,GBAWE,47 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,08-09-2024,08-09-2024,,,0,OPD,
14466,08-09-2024,KENYASE /WEIJA   OBLOGO,79 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.22 [Diabetes mellitus due to underlying condition with diabetic chronic kidney disease]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion | Stat |  For 1 Days  ],,,,08-09-2024,08-09-2024,,,135,OPD,
14500,07-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,07-09-2024,07-09-2024,,,30,OPD,
14593,07-09-2024,WEST HILL,63 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,07-09-2024,07-09-2024,,,10,OPD,
14598,07-09-2024,NEW BORTIANOR,51 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,INSURANCE AGENT,,07-09-2024,07-09-2024,,,0,OPD,
14600,07-09-2024,OLD BARRIER  APLAKU ,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,07-09-2024,07-09-2024,,,0,OPD,
14654,07-09-2024,ABLEKUMA FANMILK,38 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Non-Insured,"METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection | TDS |  For 1 Days  ], ORAL REHYDRATION SALTS [  O.R.S. | 25G | Powder | PRN |  For 1 Days  ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection | Stat |  For 1 Days  ], ZINC TABLET 20MG [ ZINC SULPHATE | 20MG | Tablet | OD |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 5 Days  ]","METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection ], ORAL REHYDRATION SALTS [  O.R.S. | 25G | Powder ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection ], ZINC TABLET 20MG [ ZINC SULPHATE | 20MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",,,07-09-2024,07-09-2024,,,150,OPD,
14737,06-09-2024,NEW-WEIJA,55 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,WAREHOUSE OFFICER,,06-09-2024,06-09-2024,,,20,OPD,
14742,06-09-2024,tetegu,54 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,06-09-2024,06-09-2024,,,0,OPD,
14813,06-09-2024,WEIJA UPPER ,49 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | BDS |  For 60 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 60 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 60 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ]","PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,06-09-2024,06-09-2024,,,10,OPD,
14817,06-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,06-09-2024,06-09-2024,,,50,OPD,
14826,06-09-2024,GBAWE,66 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ASCORBIC ACID TABLET 1G[ (VITAMIN C) | 1000MG | Tablet | OD |  For 10 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ASCORBIC ACID TABLET 1G[ (VITAMIN C) | 1000MG | Tablet ]",,,06-09-2024,06-09-2024,,,10,OPD,
14839,06-09-2024,"GBAWE 
DJAMAH",28 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",BEATICIAN,,06-09-2024,06-09-2024,,,60,OPD,
14962,06-09-2024,SCC RED TOP,55 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E13.9 [Other specified diabetes mellitus: Without complications]  ==> OLD,"I15.9 [Secondary hypertension, unspecified]  ==> OLD, R05.00 [Cough]  ==> NEW",No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 0 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 0 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ], SIMPLE LINCTUS ADULT BPC [ SIMPLE LINTUS ADULT | 100ML | Mixture | TID |  For 7 Days  ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet | BID |  For 5 Days  ]",,Unemployed,,06-09-2024,06-09-2024,,,10,OPD,
14964,06-09-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,06-09-2024,06-09-2024,,,30,OPD,
14991,06-09-2024,"KASOA , NYANYANO ",84 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 60 Days  ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet ]",,,06-09-2024,06-09-2024,,,10,OPD,1663/17 MR-6B-E6-38
14997,06-09-2024,SCC REDTOP,65 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,"L01.1 [Impetiginization of other dermatoses]  ==> NEW, Z87.11 [Personal history of peptic ulcer disease]  ==> OLD, I10.00 [Essential (primary) hypertension]  ==> OLD, G58.9 [Mononeuropathy, unspecified]  ==> OLD",No,Insured,"CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | Nocte |  For 10 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], FLUCLOXACILLIN+AMOXICILLIN[ FLUXAMOX | 500MG | Capsule | TID |  For 7 Days  ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension | TID |  For 7 Days  ]","CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], FLUCLOXACILLIN+AMOXICILLIN[ FLUXAMOX | 500MG | Capsule ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension ]",,,06-09-2024,06-09-2024,,,10,OPD,
15089,06-09-2024,KASOA ,73 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,Unemployed,,06-09-2024,06-09-2024,,,30,OPD,
15095,06-09-2024,TETEGU  MIAMI,42 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"K27.0 [Peptic ulcer, site unspecified: Acute with haemorrhage]  ==> NEW",No,Insured,"OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | OD |  For 1 Days  ]",,TRADER,,06-09-2024,06-09-2024,,,170,OPD,
15177,06-09-2024,GBAWE ZERO,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,06-09-2024,06-09-2024,,,0,OPD,
15185,06-09-2024,sakama,72 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BDS |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 60 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ]",,,,06-09-2024,06-09-2024,,,10,OPD,
15210,06-09-2024,ODORKOR,43 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,06-09-2024,06-09-2024,,,10,OPD,
15491,05-09-2024,"WEIJA
MANDELA",49 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,05-09-2024,05-09-2024,,,0,OPD,
15506,05-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,05-09-2024,05-09-2024,,,20,OPD,
15574,05-09-2024,BORTIANOR-APLAKU,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], ANTIOXIDANTS/LYCOPENE/AMINO ACIDS/DHA/ALPHA LIPOIC[ SIDME PRO |  |  | BDS |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ANTIOXIDANTS/LYCOPENE/AMINO ACIDS/DHA/ALPHA LIPOIC[ SIDME PRO |  |  ]",,,05-09-2024,05-09-2024,,,10,OPD,
15575,05-09-2024,malla,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,05-09-2024,05-09-2024,,,10,OPD,
15576,05-09-2024,WEIJA,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",TRADER,,05-09-2024,05-09-2024,,,15,OPD,
15578,05-09-2024,KWASHIEMAN,57 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,05-09-2024,05-09-2024,,,0,OPD,
15579,05-09-2024,SCC  -AZUMA  DAM  SIDE,76 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ],,Pensioner,,05-09-2024,05-09-2024,,,0,OPD,
15590,05-09-2024,"TUBA, ROUNDABOUT",68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",,,05-09-2024,05-09-2024,,,10,OPD,
15593,05-09-2024,ODORKOR OFFICIAL TOWN,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,05-09-2024,05-09-2024,,,0,OPD,
15594,05-09-2024,KASOA,67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured," TABLET BISOPROLOL 5MG[ BISOPROLOL 5MG | 5MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]",,,,05-09-2024,05-09-2024,,,0,OPD,
15598,05-09-2024,kasoa,78 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ]","NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,05-09-2024,05-09-2024,,,0,OPD,
15714,05-09-2024,amanfo,33 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ],,,,05-09-2024,05-09-2024,,,0,OPD,
15722,05-09-2024,b ortianor,21 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]",,,,05-09-2024,05-09-2024,,,0,OPD,
15747,05-09-2024,KASOA-LAMPTEY,64 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 0 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 0 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 0 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 0 Days  ]",,Retired,,05-09-2024,05-09-2024,,,0,OPD,
15766,05-09-2024,"NEW WEIJA, NEW VISION HOTEL",14 Year(s),Female,DIETERAPY,General Consultation Child,,No Outcome,NA ,E10.65 [Type 1 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Non-Insured,,,student,,05-09-2024,05-09-2024,,,50,OPD,
15786,05-09-2024,"TAIFA, NORWAY",68 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,05-09-2024,05-09-2024,,,10,OPD,
15790,05-09-2024,AWOSHIE,62 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E10.40 [Type 1 diabetes mellitus with diabetic neuropathy, unspecified]  ==> NEW",G50.1 [Atypical facial pain]  ==> NEW,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BID |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",AUTO MECHANIC,,05-09-2024,05-09-2024,,,70,OPD,
15835,05-09-2024,OLD BARRIER  APLAKU ,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,05-09-2024,05-09-2024,,,30,OPD,
15929,05-09-2024,GBAWE,47 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,05-09-2024,05-09-2024,,,0,OPD,
16066,05-09-2024,KWASHIEMAN,61 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,05-09-2024,05-09-2024,,,0,OPD,
16403,04-09-2024,NEW-WEIJA,55 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,WAREHOUSE OFFICER,,04-09-2024,04-09-2024,,,70,OPD,
16414,04-09-2024,tetegu,54 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,04-09-2024,04-09-2024,,,0,OPD,
16438,04-09-2024,OFANKOR - KASOA ,60 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,driver,,04-09-2024,04-09-2024,,,10,OPD,
16481,04-09-2024,upper weija ,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,04-09-2024,04-09-2024,,,10,OPD,
16583,04-09-2024,"NEW BORTIANOR
FINNEY HOSPITAL",67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 60 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,04-09-2024,04-09-2024,,,10,OPD,
16589,04-09-2024,WEIJA APLAKU,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,04-09-2024,04-09-2024,,,0,OPD,
16592,04-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,04-09-2024,04-09-2024,,,30,OPD,
16593,04-09-2024,BLOCK FACTORY,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I15.1 [Hypertension secondary to other renal disorders]  ==> OLD,No,Insured,"POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel | PRN |  For 2 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BDS |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,04-09-2024,04-09-2024,,,0,OPD,
16598,04-09-2024,MALLAM ABASE,52 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,,No,Insured,,,,,04-09-2024,04-09-2024,,,90,OPD,
16649,04-09-2024,mccarthy,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,04-09-2024,04-09-2024,,,0,OPD,
16669,04-09-2024,GBAWE ZERO,61 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.29 [Diabetes mellitus due to underlying condition with other diabetic kidney complication]  ==> OLD,,No,Non-Insured,SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ],SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ],caterer,,04-09-2024,04-09-2024,,,155,OPD,
16698,04-09-2024,ODORKOR,40 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,N21.8 [Other lower urinary tract calculus]  ==> NEW,No,Non-Insured,"CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ]","CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",Unemployed,,04-09-2024,04-09-2024,,,70,OPD,
16814,04-09-2024,NEW BORTIANOR,51 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,INSURANCE AGENT,,04-09-2024,04-09-2024,,,0,OPD,
16837,04-09-2024,KASOA ,73 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,Unemployed,,04-09-2024,04-09-2024,,,10,OPD,
16926,04-09-2024,GBAWE  CP,47 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,caterer,,04-09-2024,04-09-2024,,,50,OPD,
17078,04-09-2024,KASOA,70 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,04-09-2024,04-09-2024,,,50,OPD,
17359,03-09-2024,OFANKOR - KASOA ,60 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,driver,,03-09-2024,03-09-2024,,,40,OPD,
17360,03-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,03-09-2024,03-09-2024,,,0,OPD,
17401,03-09-2024,"AGAPE
GONSE",50 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,N34.1 [Nonspecific urethritis]  ==> OLD,No,Insured,"CEFUROXIME TABLET 250MG[ CEFUROXIME | 250MG | Tablet | BDS |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ]",,TRADER,,03-09-2024,03-09-2024,,,55,OPD,
17423,03-09-2024,GBAWE,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,03-09-2024,03-09-2024,,,0,OPD,
17431,03-09-2024,KASOA-LAMPTEY MILLS,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,03-09-2024,03-09-2024,,,0,OPD,
17435,03-09-2024,"ABLEKUMA , AGAPE",51 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,03-09-2024,03-09-2024,,,0,OPD,
17504,03-09-2024,GBAWE TOP BASE,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 90 Days  ], TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet | BDS |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ], TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Unemployed,,03-09-2024,03-09-2024,,,55,OPD,
17515,03-09-2024,"NEW GBAWE , TIME SPOT",53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | BID |  For 90 Days  ]","VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,03-09-2024,03-09-2024,,,10,OPD,
17516,03-09-2024,ABLEKUMA GALILEA,64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,03-09-2024,03-09-2024,,,0,OPD,
17518,03-09-2024,WEIJA OPP CATERPILLAR RD,67 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel | PRN |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel ]",Retired,,03-09-2024,03-09-2024,,,5,OPD,
17519,03-09-2024,AMANFRO  QUARTER,40 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet | BDS |  For 60 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",CLEANER,,03-09-2024,03-09-2024,,,10,OPD,
17537,03-09-2024,ABLEKUMA,52 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",,,03-09-2024,03-09-2024,,,105,OPD,
17666,03-09-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,03-09-2024,03-09-2024,,,30,OPD,
17685,03-09-2024,WEIJA,51 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E10.21 [Type 1 diabetes mellitus with diabetic nephropathy]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",ELECTRICAL TECHNICIAN,,03-09-2024,03-09-2024,,,0,OPD,
17747,03-09-2024,ODORKOR OFF TOWN,60 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Non-Insured,"OLOPATADINE HCL EYE DROP[ OLOHISTINE | 0.1% | Drops | TDS |  For 14 Days  ], NORMO TEARS EYE DROP (HYDROXYPROPYL METHYL CELLULOSE)[  |  |  | QID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","OLOPATADINE HCL EYE DROP[ OLOHISTINE | 0.1% | Drops ], NORMO TEARS EYE DROP (HYDROXYPROPYL METHYL CELLULOSE)[  |  |  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Unemployed,,03-09-2024,03-09-2024,,,0,OPD,
17750,03-09-2024,GBAWE,47 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,03-09-2024,03-09-2024,,,0,OPD,
17753,03-09-2024,TIPPER,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]",,,,03-09-2024,03-09-2024,,,0,OPD,
17759,03-09-2024,gbawe,84 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet | OD |  For 7 Days  ],DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet ],,,03-09-2024,03-09-2024,,,10,OPD,
17860,03-09-2024,OLD BARRIER  APLAKU ,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 60 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ]",,,03-09-2024,03-09-2024,,,10,OPD,
17896,03-09-2024,KASOA ,73 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",Unemployed,,03-09-2024,03-09-2024,,,15,OPD,
17904,03-09-2024,GBAWE,89 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | OD |  For 90 Days  ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | TID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | BDS |  For 30 Days  ], ASCORBIC ACID TABLET 1G[ (VITAMIN C) | 1000MG | Tablet | OD |  For 10 Days  ]","AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ], ASCORBIC ACID TABLET 1G[ (VITAMIN C) | 1000MG | Tablet ]",,,03-09-2024,03-09-2024,,,10,OPD,
17978,03-09-2024,"OMANJOR
DWENEWOHO",71 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,,No,Insured,,,TRADER,,03-09-2024,03-09-2024,,,35,OPD,
18197,03-09-2024,KASOA-BROADCASTING ,51 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.69 [Type 2 diabetes mellitus with other specified complication]  ==> OLD,,No,Insured,,,Unemployed,,03-09-2024,03-09-2024,,,100,OPD,
18218,03-09-2024,KASOA-BROADCASTING ,51 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.69 [Type 2 diabetes mellitus with other specified complication]  ==> OLD,,No,Insured,,,Unemployed,,03-09-2024,03-09-2024,,,60,OPD,
18315,02-09-2024,OFANKOR - KASOA ,60 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,driver,,02-09-2024,02-09-2024,,,40,OPD,
18346,02-09-2024,KWASHIEMAN,57 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,02-09-2024,02-09-2024,,,10,OPD,
18393,02-09-2024,tetegu,48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 14 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 14 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 14 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 14 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 14 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,02-09-2024,02-09-2024,,,10,OPD,
18400,02-09-2024,APLUKU,50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | Daily |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,02-09-2024,02-09-2024,,,10,OPD,
18405,02-09-2024,TETEGU,84 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | 6x/day |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,02-09-2024,02-09-2024,,,0,OPD,
18414,02-09-2024,scc red top ,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Non-Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ]",,,02-09-2024,02-09-2024,,,10,OPD,
18415,02-09-2024,mallam station,60 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 0 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ]",,,,02-09-2024,02-09-2024,,,10,OPD,
18416,02-09-2024,"AGONA SWEDRU, MAHONDWE",58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],FARMER,,02-09-2024,02-09-2024,,,0,OPD,
18417,02-09-2024,ODORKOR STATION ,40 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Insured,"LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 30 Days  ]","LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ]",TRADER,,02-09-2024,02-09-2024,,,65,OPD,
18418,02-09-2024,ablekuman,69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M79.1 [Myalgia]  ==> NEW",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 60 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ]",,,02-09-2024,02-09-2024,,,0,OPD,
18497,02-09-2024,ablekuman nic,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], VILDAGLIPTIN+METFORMIN[ GALVUS MET | 50MG/1000MG | Tablet | BID |  For 30 Days  ], GLICLAZIDE [ DIAMICRON | 80MG | Tablet | BDS |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VILDAGLIPTIN+METFORMIN[ GALVUS MET | 50MG/1000MG | Tablet ], GLICLAZIDE [ DIAMICRON | 80MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ]",,,02-09-2024,02-09-2024,,,0,OPD,
18509,02-09-2024,red top,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,02-09-2024,02-09-2024,,,0,OPD,
18520,02-09-2024,AGAPE UP TWON,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.42 [Diabetes mellitus due to underlying condition with diabetic polyneuropathy]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",Para Professional,,02-09-2024,02-09-2024,,,0,OPD,
18525,02-09-2024,"AMANFRO
GALILEA",57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Non-Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,02-09-2024,02-09-2024,,,10,OPD,
18530,02-09-2024,REDTOP WEIJA ,76 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",Pensioner,,02-09-2024,02-09-2024,,,15,OPD,
18591,02-09-2024,WEIJA,59 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",caterer,,02-09-2024,02-09-2024,,,0,OPD,
18616,02-09-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,02-09-2024,02-09-2024,,,30,OPD,
18625,02-09-2024,AMANFRO-BRIGADE,68 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,02-09-2024,02-09-2024,,,0,OPD,
18684,02-09-2024,MAMPROBI,64 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | Daily |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ]",Pensioner,,02-09-2024,02-09-2024,,,10,OPD,
18700,02-09-2024,"gbawe
",71 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,02-09-2024,02-09-2024,,,0,OPD,
18704,02-09-2024,weija new twon,55 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 100ML[ DREZ  | 100ML | Solution | Daily |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 100ML[ DREZ  | 100ML | Solution ]",,,02-09-2024,02-09-2024,,,0,OPD,
18753,02-09-2024,NEW BORTIANOR,51 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,INSURANCE AGENT,,02-09-2024,02-09-2024,,,20,OPD,
18852,02-09-2024,OFANKOR - KASOA ,60 Year(s),Male,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,driver,,02-09-2024,02-09-2024,,,100,OPD,
19071,02-09-2024,ODORKOR,43 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,02-09-2024,02-09-2024,,,10,OPD,
19344,01-09-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,01-09-2024,01-09-2024,,,30,OPD,
19397,01-09-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,01-09-2024,01-09-2024,,,140,OPD,
19412,01-09-2024,GBAWE,47 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,,,01-09-2024,01-09-2024,,,0,OPD,
19492,01-09-2024,KWASIBU,38 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E10.65 [Type 1 diabetes mellitus with hyperglycemia]  ==> NEW,"N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Non-Insured,"GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | Stat |  For 1 Days  ]","GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ]",Unemployed,,01-09-2024,01-09-2024,,,405,OPD,
